Health
Gut microbiome can modulate the immune response in liver cancer patients with NAFLD – News-Medical.Net
The distinctive gut microbiome profile of a person with liver cancer linked to non-alcoholic fatty liver disease (NAFLD) could be the key to predicting someone’s…
The distinctive gut microbiome profile of a person with liver cancer linked to non-alcoholic fatty liver disease (NAFLD) could be the key to predicting someone’s risk of developing the cancer, say researchers from the UNSW Microbiome Research Centre (MRC).
Their new study, published in Nature Communications recently, found the gut microbiome – the kingdom of microorganisms living in our digestive tracts – can modulate the immune response in liver cancer patients with NAFLD, in a way that promotes…
-
Business16 hours agoThis ASX 200 healthcare stock crashed 14% to 4-year low. Here’s what happened
-
Business20 hours agoThis leading broker thinks the CSL share price can climb 40%
-
Business12 hours agoDicker Data rides the AI trend to double digit growth
-
Business15 hours agoForget CBA shares, this ASX 200 financials stock could be a better buy